Nutex Health (NASDAQ:NUTX – Get Free Report) had its target price lowered by research analysts at Benchmark from $1.50 to $1.00 in a note issued to investors on Thursday, Benzinga reports. The firm presently has a “buy” rating on the stock. Nutex Health Price Performance Shares of NASDAQ:NUTX remained flat at $0.14 during trading on […]